Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Adjunctive cenobamate reduced focal (partial)-onset seizure frequency, in a dose-related fashion. Treatment-emergent adverse events were most frequent in the highest dose group. Cenobamate appears to be an effective treatment option in patients with uncontrolled focal seizures.
10 March, 2020
Free monthly webinars with topics related to rare and complex epilepsies and research.
5 March, 2020
ILAE's Leadership Development Award provides a unique opportunity to receive leadership development training and to network with rising leaders from around the globe. Approximately 30 candidates will be selected.
4 March, 2020
The first stage of the election for the next ILAE Executive Committee (2021-2025 term) is the election of the President. Each Chapter will submit one ballot only, voting for one candidate only. Individuals cannot vote, but members of Chapters are encouraged to contact their committee and inform them of their preferred candidate.
27 February, 2020
The Roman Colosseum was bathed in purple for,International Epilepsy Day. This day is a joint initiative by the International Bureau for Epilepsy (IBE) and the ILAE and is a special event which promotes awareness of epilepsy in more than 120 countries each year.
11 February, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community